Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?Zacks Investment Research • 10/03/23
Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/29/23
Accelerate Diagnostics Announces Successful Completion of Debt Restructuring Support Agreement, Supporting Advancement of Next-Generation Platform WavePRNewsWire • 06/13/23
Is Accelerate Diagnostics (AXDX) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 05/23/23
Accelerate Diagnostics (AXDX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 04/03/23
Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial ResultsPRNewsWire • 03/29/23
Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year resultsPRNewsWire • 03/15/23
Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacementPRNewsWire • 03/15/23
Accelerate Diagnostics announces appointment of Hany Massarany to Chairman of Board of DirectorsPRNewsWire • 03/08/23
Accelerate Diagnostics submits 510(K) application to FDA for Gram-negative menu expansion and breakpoint updates for the Accelerate PhenoTest® BC kitPRNewsWire • 12/19/22
Accelerate Diagnostics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmNewsfile Corp • 11/15/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Accelerate Diagnostics, Inc. - AXDXPRNewsWire • 11/14/22
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of InvestorsBusiness Wire • 10/27/22
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces It Is Investigating Claims Against Accelerate Diagnostics, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 10/27/22
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Accelerate Diagnostics, Inc. (AXDX) on Behalf of InvestorsBusiness Wire • 10/26/22